Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

The treatment was not recommended due to limited effectiveness and significant side effects.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

RCS-01 cell therapy is safe and improves skin gene expression.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Gamma radiation enhances the antioxidant properties of Hibiscus rosa-sinensis extract without causing toxicity.

CEC levels may be a useful marker for predicting prostate cancer progression.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Higher MPV and CRP levels may indicate more severe alopecia areata.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

High calcium levels in hair may indicate early breast cancer.

A 30 Gy radiation dose effectively causes severe radiodermatitis in rabbits.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Radiation increases cell death in hair follicles, but certain treatments can protect against this effect.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.